BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hausegger KA, Karnel F, Georgieva B, Tauss J, Portugaller H, Deutschmann H, Berghold A. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft. J Vasc Interv Radiol. 2004;15:239-248. [PMID: 15028808 DOI: 10.1097/01.rvi.0000116194.44877.c1] [Cited by in Crossref: 93] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Casadaban LC, Gaba RC. Percutaneous Portosystemic Shunts: TIPS and Beyond. Semin Intervent Radiol 2014;31:227-34. [PMID: 25177082 DOI: 10.1055/s-0034-1382789] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
2 Wu Q, Jiang J, He Y, Jiang T, Zhou S. Transjugular intrahepatic portosystemic shunt using the FLUENCY expanded polytetrafluoroethylene-covered stent. Exp Ther Med. 2013;5:263-266. [PMID: 23251280 DOI: 10.3892/etm.2012.776] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
3 Owen JW, Saad NE, Foster G, Fowler KJ. The Feasibility of Using Volumetric Phase-Contrast MR Imaging (4D Flow) to Assess for Transjugular Intrahepatic Portosystemic Shunt Dysfunction. J Vasc Interv Radiol 2018;29:1717-24. [PMID: 30396843 DOI: 10.1016/j.jvir.2018.07.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Rajoriya N, Tripathi D. Historical overview and review of current day treatment in the management of acute variceal haemorrhage. World J Gastroenterol. 2014;20:6481-6494. [PMID: 24914369 DOI: 10.3748/wjg.v20.i21.6481] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
5 Luo XF, Nie L, Wang Z, Tsauo J, Liu LJ, Yu Y, Zhou B, Tang CW, Li X. Stent-grafts for the treatment of TIPS dysfunction: fluency stent vs Wallgraft stent. World J Gastroenterol. 2013;19:5000-5005. [PMID: 23946607 DOI: 10.3748/wjg.v19.i30.5000] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
6 Gaba RC, Bui JT, Cotler SJ, Kallwitz ER, Mengin OT, Martinez BK, Berkes JL, Carrillo TC, Knuttinen MG, Owens CA. Rebleeding rates following TIPS for variceal hemorrhage in the Viatorr era: TIPS alone vs TIPS with variceal embolization. Hepatol Int. 2010;4:749-756. [PMID: 21286346 DOI: 10.1007/s12072-010-9206-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
7 Owen JM, Gaba RC. Transjugular Intrahepatic Portosystemic Shunt Dysfunction: Concordance of Clinical Findings, Doppler Ultrasound Examination, and Shunt Venography. J Clin Imaging Sci. 2016;6:29. [PMID: 27563495 DOI: 10.4103/2156-7514.186510] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
8 Cejna M. Should stent-grafts replace bare stents for primary transjugular intrahepatic portosystemic shunts? Semin Intervent Radiol 2005;22:287-99. [PMID: 21326707 DOI: 10.1055/s-2005-925555] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
9 Geeroms B, Laleman W, Laenen A, Heye S, Verslype C, van der Merwe S, Nevens F, Maleux G. Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients: Long-term patency and clinical outcome results. Eur Radiol 2017;27:1795-803. [PMID: 27629421 DOI: 10.1007/s00330-016-4570-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
10 Pinter SZ, Rubin JM, Kripfgans OD, Novelli PM, Vargas-Vila M, Hall AL, Fowlkes JB. Volumetric blood flow in transjugular intrahepatic portosystemic shunt revision using 3-dimensional Doppler sonography. J Ultrasound Med 2015;34:257-66. [PMID: 25614399 DOI: 10.7863/ultra.34.2.257] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
11 Saad WE, Darcy MD. Transjugular Intrahepatic Portosystemic Shunt (TIPS) vs Balloon-occluded Retrograde Transvenous Obliteration (BRTO) for the Management of Gastric Varices. Semin Intervent Radiol. 2011;28:339-349. [PMID: 22942552 DOI: 10.1055/s-0031-1284461] [Cited by in Crossref: 73] [Cited by in F6Publishing: 55] [Article Influence: 8.1] [Reference Citation Analysis]
12 Hsu MC, Weber CN, Stavropoulos SW, Clark TW, Trerotola SO, Shlansky-Goldberg RD, Soulen MC, Nadolski GJ. Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes. World J Hepatol 2017;9:603-12. [PMID: 28515846 DOI: 10.4254/wjh.v9.i12.603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
13 Shi Y, Tian X, Hu J, Zhang J, Zhang C, Yang Y, Qin C. Efficacy of transjugular intrahepatic portosystemic shunt with adjunctive embolotherapy with cyanoacrylate for esophageal variceal bleeding. Dig Dis Sci. 2014;59:2325-2332. [PMID: 24748182 DOI: 10.1007/s10620-014-3150-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
14 He FL, Wang L, Zhao HW, Fan ZH, Zhao MF, Dai S, Yue ZD, Liu FQ. Transjugular intrahepatic portosystemic shunt for severe jaundice in patients with acute Budd-Chiari syndrome. World J Gastroenterol. 2015;21:2413-2418. [PMID: 25741149 DOI: 10.3748/wjg.v21.i8.2413] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
15 Qin JP, Jiang MD, Tang W, Wu XL, Yao X, Zeng WZ, Xu H, He QW, Gu M. Clinical effects and complications of TIPS for portal hypertension due to cirrhosis: a single center. World J Gastroenterol. 2013;19:8085-8092. [PMID: 24307804 DOI: 10.3748/wjg.v19.i44.8085] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
16 Chen H, Bai M, Qi X, Liu L, He C, Yin Z, Fan D, Han G. Child-Na score: a predictive model for survival in cirrhotic patients with symptomatic portal hypertension treated with TIPS. PLoS One 2013;8:e79637. [PMID: 24244533 DOI: 10.1371/journal.pone.0079637] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
17 Yao X, Zhou H, Huang S, Tang SH, Qin JP. Effects of transjugular intrahepatic portosystemic shunt using the Viatorr stent on hepatic reserve function in patients with cirrhosis. World J Clin Cases. 2021;9:1532-1542. [PMID: 33728297 DOI: 10.12998/wjcc.v9.i7.1532] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Saad WE. The history and future of transjugular intrahepatic portosystemic shunt: food for thought. Semin Intervent Radiol. 2014;31:258-261. [PMID: 25177087 DOI: 10.1055/s-0034-1382794] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
19 Zhao JB, Feng C, Zhu QH, He XF, Li YH, Chen Y. Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol. 2014;20:1602-1607. [PMID: 24587637 DOI: 10.3748/wjg.v20.i6.1602] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
20 Qi XS, Bai M, Yang ZP, Fan DM. Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: an evidence-based review. World J Gastroenterol. 2014;20:6470-6480. [PMID: 24914368 DOI: 10.3748/wjg.v20.i21.6470] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
21 Kim SK, Belikoff BG, Guevara CJ, Park SJ. An Algorithm for Management After Transjugular Intrahepatic Portosystemic Shunt Placement According to Clinical Manifestations. Dig Dis Sci. 2017;62:305-318. [PMID: 28058594 DOI: 10.1007/s10620-016-4399-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Patidar KR, Sydnor M, Sanyal AJ. Transjugular intrahepatic portosystemic shunt. Clin Liver Dis 2014;18:853-76. [PMID: 25438287 DOI: 10.1016/j.cld.2014.07.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
23 Spira D, Wiskirchen J, Lauer U, Ketelsen D, Nikolaou K, Wiesinger B. Implantability, Complications, and Follow-Up After Transjugular Intrahepatic Portosystemic Stent-Shunt Creation With the 6F Self-Expanding Sinus-SuperFlex-Visual Stent. Iran J Radiol 2016;13:e28689. [PMID: 27853493 DOI: 10.5812/iranjradiol.28689] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
24 Punamiya SJ, Amarapurkar DN. Role of TIPS in Improving Survival of Patients with Decompensated Liver Disease. Int J Hepatol 2011;2011:398291. [PMID: 21994854 DOI: 10.4061/2011/398291] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
25 Sarin SK, Kumar A, Chawla YK, Baijal SS, Dhiman RK, Jafri W, Lesmana LA, Guha Mazumder D, Omata M, Qureshi H, Raza RM, Sahni P, Sakhuja P, Salih M, Santra A, Sharma BC, Sharma P, Shiha G, Sollano J; Members of the APASL Working Party on Portal Hypertension. Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int 2007;1:398-413. [PMID: 19669336 DOI: 10.1007/s12072-007-9010-9] [Cited by in Crossref: 105] [Cited by in F6Publishing: 75] [Article Influence: 7.5] [Reference Citation Analysis]
26 Wallace MJ, Madoff DC. Transjugular intrahepatic portosystemic shunts in patients with hepatic malignancy. Semin Intervent Radiol. 2005;22:309-315. [PMID: 21326709 DOI: 10.1055/s-2005-925557] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]